Alnylam Wins FDA Approval For Givlaari, Its Second RNAi Drug

 
• By Jessica Merrill
  
approved label. approved blue band sign. approved. approved stamp on white background - Vector
Alnylam's Givlaari is the first drug approved for AHP
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip